$VINCU Vincerx Pharma, Inc. Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Vincerx Pharma, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Vincerx Pharma, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Vincerx Pharma, Inc. for free.
IRS Number: 833197402
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: VINCU
Company Address: 260 SHERIDAN AVENUE SUITE 400 PALO ALTO 94306
Former name: LifeSci Acquisition Corp., date of change: 2019-12-06
Former name: Vincera Pharma, Inc., date of change: 2020-12-23
Vincerx Pharma, Inc. Latest Insider Transactions
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 14 2021 | VINCU | Vincerx Pharma, In ... | Bushnell Laura I. | Director | Option Exercise | A | 16.34 | 20,000 | 326,800 | 20,000 | |
| May 14 2021 | VINCU | Vincerx Pharma, In ... | McDonald Andrew I | Director | Option Exercise | A | 16.34 | 20,000 | 326,800 | 20,000 | |
| May 14 2021 | VINCU | Vincerx Pharma, In ... | LOWE CHRISTOPHER P. | Director | Option Exercise | A | 16.34 | 20,000 | 326,800 | 20,000 | |
| May 14 2021 | VINCU | Vincerx Pharma, In ... | Druker Brian | Director | Option Exercise | A | 16.34 | 20,000 | 326,800 | 20,000 | |
| May 14 2021 | VINCU | Vincerx Pharma, In ... | Salva Francisco D. | Director | Option Exercise | A | 16.34 | 20,000 | 326,800 | 20,000 | |
| May 14 2021 | VINCU | Vincerx Pharma, In ... | Stevens Ruth E. | Director | Option Exercise | A | 16.34 | 20,000 | 326,800 | 20,000 | |
| May 14 2021 | VINCU | Vincerx Pharma, In ... | Lee John H. | Director | Option Exercise | A | 16.34 | 20,000 | 326,800 | 20,000 | |
| Mar 17 2021 | LSAC | Vincerx Pharma, In ... | THOMAS TOM C | See Remarks | Option Exercise | A | 23.75 | 175,000 | 4,156,250 | 175,000 | |
| Feb 02 2021 | LSAC | Vincerx Pharma, In ... | McDonald Andrew I | Director | Buy | J | 0.00 | 808,471 | 0 | 808,471 | 0 to 808.5 K |
| Feb 02 2021 | LSAC | Vincerx Pharma, In ... | McDonald Andrew I | Director | Sell | J | 0.00 | 1,616,942 | 0 | 0 | 1.6 M to 0 (-100.00 %) |
| Dec 28 2020 | LSAC | Vincera Pharma, In ... | Hamdy Ahmed MD | President and CEO | Grant | A | 0.00 | 1,618,199 | 0 | 1,618,199 | 0 to 1.6 M |
| Dec 28 2020 | LSAC | Vincera Pharma, In ... | Seelenberger Alexander A. | Chief Financial Off ... | Option Exercise | A | 19.00 | 200,000 | 3,800,000 | 200,000 | |
| Dec 28 2020 | LSAC | Vincera Pharma, In ... | Izumi Raquel E. | Chief Operations Of ... | Grant | A | 0.00 | 1,618,199 | 0 | 1,618,199 | 0 to 1.6 M |
| Dec 28 2020 | LSAC | Vincera Pharma, In ... | McDonald Andrew I | Director | Option Exercise | A | 19.00 | 6,667 | 126,673 | 6,667 | |
| Dec 28 2020 | LSAC | Vincera Pharma, In ... | Lee John H. | Director | Option Exercise | A | 19.00 | 6,667 | 126,673 | 6,667 |